A Study of SPY072 in Rheumatic Disease
Public ClinicalTrials.gov record NCT07148414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Study to Assess the Efficacy and Safety of SPY002-072 in Adults With Moderately to Severely Active Rheumatologic Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, double-blind, placebo-controlled, Phase 2, proof-of-concept basket study with the goal of assessing the efficacy and safety of SPY072 compared to placebo in adults (aged ≥18 years) with rheumatic disease (RD).
Study identification
- NCT ID
- NCT07148414
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 285 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2025 (Actual)
- Primary completion
- Oct 31, 2026 (Estimated)
- Completion
- Mar 31, 2028 (Estimated)
- Last update posted
- Jun 5, 2026
2025 – 2028
United States locations
- U.S. sites
- 18
- U.S. states
- 7
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 113 | Avondale | Arizona | 85392 | — |
| Site 118 | Tucson | Arizona | 85748 | — |
| Site 114 | Chula Vista | California | 91910 | — |
| Site 111 | Covina | California | 91722 | — |
| Site 108 | Tujunga | California | 91042 | — |
| Site 112 | Upland | California | 91786 | — |
| Site 107 | Whittier | California | 90602 | — |
| Site 115 | Aventura | Florida | 33180 | — |
| Site 109 | Hialeah | Florida | 33016 | — |
| Site 106 | Ormond Beach | Florida | 32174 | — |
| Site 110 | Tampa | Florida | 33614 | — |
| Site 116 | Willowbrook | Illinois | 60527 | — |
| Site 119 | Rockville | Maryland | 20850 | — |
| Site 104 | Duncansville | Pennsylvania | 16635 | — |
| Site 105 | Corpus Christi | Texas | 78404 | — |
| Site 120 | Irving | Texas | 75039 | — |
| Site 103 | Tomball | Texas | 77375 | — |
| Site 102 | Tomball | Texas | 77377 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07148414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2026 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07148414 live on ClinicalTrials.gov.